High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma
Articolo
Data di Pubblicazione:
1994
Citazione:
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma / A. M. Gianni, C. Tarella, M. Bregni, S. Siena, F. Lombardi, L. Gandola, D. Caracciolo, A. Stern, G. Bonadonna, M. Boccadoro. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 12:3(1994 Mar), pp. 503-9-509.
Abstract:
To assess the toxicity, efficacy, and applicability of high-dose therapy with bone marrow and/or peripheral-blood autotransplantation in high-risk, previously untreated patients with multiple myeloma.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Drug Administration Schedule; Recombinant Proteins; Combined Modality Therapy; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Pilot Projects; Multiple Myeloma; Whole-Body Irradiation; Adult; Treatment Outcome; Antineoplastic Combined Chemotherapy Protocols; Middle Aged; Bone Marrow Transplantation; Female; Male; Survival Analysis
Elenco autori:
A. M. Gianni, C. Tarella, M. Bregni, S. Siena, F. Lombardi, L. Gandola, D. Caracciolo, A. Stern, G. Bonadonna, M. Boccadoro
Link alla scheda completa: